Jumbo phages use a protein shield to protect their DNA from bacterial attacks. A special handshake controls which molecules ...

Bacteriophages, or phages, are viruses that specifically infect bacteria. With the rise of antibiotic-resistant infections, there has been a renewed interest in phage therapy as a potential ...

In the face of rising concerns about antibiotic resistant infections, an international group of microbial experts have ...

The US government has provided almost $24 million in funding to Locus Biosciences to support a mid-stage trial of LBP-EC01, a CRISPR-engineered bacteriophage therapy in development for resistant ...

Returning to Boston this February, the Bacteriophage Therapy Summit is the only global platform for industry-dominated phage drug developers. Uniting 90+ Chief Executive Officers, Vice Presidents ...

The phage therapy market is experiencing significant growth due to the increasing prevalence of antibiotic-resistant infections and the growing interest in alternative treatments. Advances in ...

By understanding bacteriophages, scientists can develop phage therapy to treat bacterial infections that no longer respond to ...

In order to run PT service for clinicians, safe bacteriophage preparations for therapeutic use approved by appropriate authorities need to be produced and the infrastructure needed for this requires ...

Bacteriophage MarketThe global bacteriophage market, valued at USD 45.07 million in 2023, is projected to reach USD 68 million by 2033, growing at a CAGR of 4.2% over the forecast period. The ...

‘Phage therapy’ uses naturally occurring viruses called bacteriophages (from the Greek meaning ‘bacteria-eaters’) to fight bacteria. The phages used in this therapy are harmless to people ...